sglt2 inhibitor Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 1/2 (1)

Interventional (1)

The University of Texas Health Science Center at San Antonio (1)

Yes (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/haddiabetes

I am/have/hadbody mass index

I am/have/hadoral glucose tolerance test

I am/have/hadtype 2 diabetes mellitus

I am/have/hadcognitive assessment

added new label for I am/have/had

more

I am looking for

I am looking forhemoglobin a1c

I am looking forblood sugar

I am looking forglycosylated hemoglobin

I am looking forsglt2

I am looking forhba1c

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Cardiovascular Diseases
Recruiting

SGLT2 Inhibition in Older Obese Adults With Pre-diabetes

Inhibitors of the sodium-glucose co-transporter (SGLT2) are FDA-approved for the treatment of type 2 diabetes (T2DM). Their mechanism of action involves lowering of blood glucose concentration secondary to increased glucose excretion of glucose by the kidney. These drugs also improve body weight, blood pressure, and cardiac function. Based on these …

hemoglobin a1c

blood sugar

type 2 diabetes mellitus

hba1c

diabetes

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.